MindWalk Corp. (formerly BioStrand) – Medium

MindWalk Corp. (formerly BioStrand)

Pinned

Beyond AlphaFold 2: The next frontier in macromolecular structure prediction

As a testament to the recent breakthrough of deep-learning technologies in the field of (structural) bioinformatics, half of the Nobel…

Jan 21

Beyond AlphaFold 2: The next frontier in macromolecular structure prediction

Jan 21

Pinned

Multimodal language models in protein engineering: Functional clonotyping & beyond

In the beginning of 2023, ChatGPT achieved a significant milestone of 100 million users. The utilization of generative AI defined the year…

Feb 1, 2024

Multimodal language models in protein engineering: Functional clonotyping & beyond

Feb 1, 2024

Pinned

Explained: how to plot the prediction quality metrics with AlphaFold2

In a previous blog post , we discussed the importance of AlphaFold2 (as well as other, deep-learning based methods) to accelerate the…

Jan 9, 2023

Explained: how to plot the prediction quality metrics with AlphaFold2

Jan 9, 2023

A year in review: Advancing antibody discovery and beyond

As we step into 2025, we’re reflecting on a year full of significant advancements, particularly in enhancing our SaaS platform. These…

Jan 15

A year in review: Advancing antibody discovery and beyond

Jan 15

Epitope mapping: Techniques, applications, and innovations

Overview & significance of epitope mapping in targeted drug development

Dec 5, 2024

Epitope mapping: Techniques, applications, and innovations

Dec 5, 2024

Advancing rational drug design: Vector search in protein analytics

Drug discovery processes are typically organized in a step-by-step manner — going from target identification to lead optimization…

Jul 11, 2024

Advancing rational drug design: Vector search in protein analytics

Jul 11, 2024

Perspectives on in silico immunogenicity screening

At its core, immunogenicity refers to the ability of a substance, typically a drug or vaccine, to provoke an immune response within the…

Jul 4, 2024

Perspectives on in silico immunogenicity screening

Jul 4, 2024

Transforming drug design: Vector search in text analysis

AI-Driven Rational Drug Design is central to BioStrand’s mission to power the intersection of biotech discovery, biotherapeutics and AI…

Jun 13, 2024

Transforming drug design: Vector search in text analysis

Jun 13, 2024

High-throughput in silico epitope binning, with in vitro grade accuracy

Efficient, scalable antibody drug discovery and development is grounded in the high-throughput isolation of substantial quantities of…

May 30, 2024

High throughput in silico epitope binning with in vitro grade accuracy

May 30, 2024

Epitope binning explained: A powerful tool for antibody development

Epitope-based screening approaches are playing a pivotal role in the development of modern antibody therapies for various diseases…

May 7, 2024

Epitope binning explained: A powerful tool for antibody development

May 7, 2024

MindWalk Corp. (formerly BioStrand)

MindWalk Corp. (formerly BioStrand)

All-in-one biointelligence ecosystem unifying AI, data, and advanced lab research to create biologics breakthroughs.

Following

Help

Status

About

Careers

Press

Blog

Privacy

Rules

Terms

Text to speech